NIA
NIA Impact Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.07M | Sell |
15,887
-45
| -0.3% | -$20K | 2.44% | 12 |
|
|
2025
Q1 | $7.72M | Hold |
15,932
| – | – | 2.87% | 5 |
|
|
2024
Q4 | $6.42M | Sell |
15,932
-1,395
| -8% | -$562K | 2.09% | 16 |
|
|
2024
Q3 | $8.06M | Sell |
17,327
-1,452
| -8% | -$675K | 2.68% | 9 |
|
|
2024
Q2 | $8.8M | Sell |
18,779
-978
| -5% | -$458K | 3.16% | 5 |
|
|
2024
Q1 | $8.26M | Buy |
+19,757
| New | +$8.26M | 3.29% | 5 |
|
|
2023
Q2 | $6.96M | Sell |
20,046
-180
| -0.9% | -$62.5K | 3.96% | 5 |
|
|
2023
Q1 | $6.37M | Buy |
20,226
+1,051
| +5% | +$331K | 3.44% | 7 |
|
|
2022
Q4 | $5.54M | Buy |
19,175
+2,023
| +12% | +$584K | 3.22% | 6 |
|
|
2022
Q3 | $4.97M | Buy |
17,152
+9,533
| +125% | +$2.76M | 3.06% | 7 |
|
|
2022
Q2 | $2.15M | Buy |
+7,619
| New | +$2.15M | 1.29% | 30 |
|